Previous Close | $4.44 |
Intrinsic Value | $0.86 |
Upside potential | -81% |
Data is not available at this time.
Lichen China Limited operates in the financial and taxation service sector in China, specializing in providing comprehensive compliance solutions for businesses. The company's core revenue model is built on offering professional services such as financial advisory, tax planning, and regulatory compliance, primarily catering to small and medium-sized enterprises (SMEs). Its services are critical in China's complex regulatory environment, where businesses face stringent financial reporting and tax obligations. Lichen China differentiates itself through localized expertise and a deep understanding of regional regulatory frameworks, positioning it as a trusted partner for SMEs navigating financial compliance. The company operates in a highly fragmented market, competing with both local firms and larger national players. Its niche focus on compliance services allows it to maintain a steady client base, though growth is contingent on regulatory changes and economic conditions affecting SME demand for such services.
In FY 2024, Lichen China reported revenue of $41.5 million but recorded a net loss of $6.1 million, reflecting operational challenges. The diluted EPS of -$0.413 underscores profitability pressures, while negative operating cash flow of $5.6 million indicates inefficiencies in cash generation. Capital expenditures were minimal at $36,000, suggesting limited investment in growth initiatives during the period.
The company's negative earnings power highlights difficulties in translating revenue into sustainable profits. With minimal capital expenditures, Lichen China appears to prioritize cost containment over expansion, though this strategy has yet to yield positive earnings. The lack of significant debt ($61,000) suggests a conservative approach to leverage, but the negative cash flow raises questions about long-term capital efficiency.
Lichen China maintains a solid liquidity position with $26.7 million in cash and equivalents, providing a buffer against short-term liabilities. Total debt is negligible, indicating low financial risk. However, the negative operating cash flow could strain liquidity if sustained, necessitating closer monitoring of working capital management and cost structure adjustments.
The company's growth trajectory appears stagnant, with no dividends paid in FY 2024, reflecting its focus on preserving capital amid profitability challenges. The absence of significant capex or debt suggests a cautious approach to growth, possibly awaiting improved market conditions or operational turnaround before committing to expansion.
Given its negative earnings and cash flow, Lichen China's valuation likely hinges on its cash reserves and potential for operational improvement. Market expectations remain subdued, with investors likely awaiting signs of profitability recovery or strategic shifts to unlock value. The company's niche market position offers some stability but limited upside without earnings growth.
Lichen China's deep regulatory expertise and focus on SME compliance services provide a defensible niche, but profitability challenges cloud its outlook. Success depends on improving operational efficiency and potentially diversifying revenue streams. The company's strong cash position offers flexibility, but without a clear path to profitability, near-term prospects remain uncertain.
Company filings, CIK 0001876766
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |